COG-UK/DHSC-CYYJOSF

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYJOSF

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYJOSF

text: not provided


status: PUBLIC

tag: attribute

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

tag: Namespace:Oncologica UK Ltd

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: Severe acute respiratory syndrome coronavirus 2

text: active surveillance in response to outbreak

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNQIGI

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNQIGI

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNQIGI

text: not provided


COG-UK/DHSC-CYNJWXQ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNJWXQ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNJWXQ

text: not provided


COG-UK/DHSC-CYBWTNI

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBWTNI

tag: Namespace:Yourgene Health

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBWTNI

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDAGAJ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDAGAJ

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDAGAJ

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided


COG-UK/DHSC-CYDWANC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDWANC

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDWANC

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDFDRH

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDFDRH

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDFDRH

text: not provided


COG-UK/DHSC-CYYFBDD

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYYFBDD

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYFBDD

text: not provided


COG-UK/DHSC-CYNYYGG

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNYYGG

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNYYGG

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDMMIF

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDMMIF

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDMMIF

text: not provided


COG-UK/DHSC-CYYWDUB

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYWDUB

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYWDUB

text: not provided


COG-UK/DHSC-CYDQEGB

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDQEGB

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDQEGB

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYYFAQS

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYFAQS

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYFAQS

text: not provided


COG-UK/DHSC-CYDRCAC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDRCAC

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDRCAC

text: not provided


COG-UK/DHSC-CYDCPRR

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDCPRR

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDCPRR

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNTNNJ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNTNNJ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNTNNJ

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided


COG-UK/DHSC-CYBHGER

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBHGER

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBHGER

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNRPPD

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNRPPD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNRPPD

text: not provided


COG-UK/DHSC-CYDPCIY

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDPCIY

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDPCIY

text: not provided


COG-UK/DHSC-CYNGPRT

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNGPRT

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNGPRT

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBRHHS

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBRHHS

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBRHHS

text: not provided


COG-UK/DHSC-CYDUWIM

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDUWIM

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDUWIM

text: not provided


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYYOIFW

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYOIFW

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYOIFW

text: not provided


COG-UK/DHSC-CYBEPKN

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBEPKN

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBEPKN

text: not provided


COG-UK/DHSC-CYBCJEN

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBCJEN

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBCJEN

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNHPIB

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNHPIB

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNHPIB

text: not provided


COG-UK/DHSC-CYDWGOB

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDWGOB

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDWGOB

text: not provided


COG-UK/DHSC-CYDQFZB

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDQFZB

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDQFZB

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBNUDS

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBNUDS

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBNUDS

text: not provided


COG-UK/DHSC-CYDIUDP

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDIUDP

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDIUDP

text: not provided


COG-UK/DHSC-CYBCSQJ

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBCSQJ

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBCSQJ

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNZXUP

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNZXUP

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNZXUP

text: not provided


COG-UK/DHSC-CYYGYDN

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYGYDN

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYGYDN

text: not provided


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBQWIA

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBQWIA

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBQWIA

text: not provided


COG-UK/DHSC-CYNCYHB

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNCYHB

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNCYHB

text: not provided


COG-UK/DHSC-CYYFAWJ

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYFAWJ

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYFAWJ

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDGBSZ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDGBSZ

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDGBSZ

text: not provided


COG-UK/DHSC-CYNOAOA

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNOAOA

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNOAOA

text: not provided


COG-UK/DHSC-CYDAJIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDAJIC

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDAJIC

characteristic: title

text: not provided

characteristic: virus identifier


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: not provided


COG-UK/DHSC-CYBXIEO

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBXIEO

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBXIEO

text: not provided


COG-UK/DHSC-CYDJYQD

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDJYQD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDJYQD

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBWWYS

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBWWYS

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBWWYS

text: not provided


COG-UK/DHSC-CYYWEGZ

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYWEGZ

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYWEGZ

text: not provided


COG-UK/DHSC-CYNRRNN

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNRRNN

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNRRNN

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYYHABB

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYHABB

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYHABB

text: not provided


COG-UK/DHSC-CYYPENQ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYYPENQ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYPENQ

text: not provided


COG-UK/DHSC-CYNZJCN

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNZJCN

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNZJCN

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDSWHZ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDSWHZ

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDSWHZ

text: not provided


COG-UK/DHSC-CYNJBUA

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNJBUA

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNJBUA

text: not provided


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDDBFY

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDDBFY

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDDBFY

text: not provided


COG-UK/DHSC-CYDYIHD

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDYIHD

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDYIHD

text: not provided


COG-UK/DHSC-CYBYHOS

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBYHOS

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBYHOS

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDZHXE

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDZHXE

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDZHXE

text: not provided


COG-UK/DHSC-CYDRNIH

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDRNIH

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDRNIH

text: not provided


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBRCAQ

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBRCAQ

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBRCAQ

text: not provided


COG-UK/DHSC-CYBSHWB

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBSHWB

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBSHWB

text: not provided


COG-UK/DHSC-CYDWMFU

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDWMFU

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDWMFU

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBSUFJ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBSUFJ

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBSUFJ

text: not provided


COG-UK/DHSC-CYNDAXS

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNDAXS

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNDAXS

text: not provided


COG-UK/DHSC-CYBTYCA

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBTYCA

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBTYCA

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDJUEH

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDJUEH

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDJUEH

text: not provided


COG-UK/DHSC-CYBIQKG

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBIQKG

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBIQKG

text: not provided


COG-UK/DHSC-CYDHBIC

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDHBIC

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDHBIC

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBNRKZ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBNRKZ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBNRKZ

text: not provided


COG-UK/DHSC-CYNUNUN

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNUNUN

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNUNUN

text: not provided


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDFOKD

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDFOKD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDFOKD

text: not provided


COG-UK/DHSC-CYBYDGR

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBYDGR

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBYDGR

text: not provided


COG-UK/DHSC-CYDKNGX

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDKNGX

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDKNGX

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNFFJT

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNFFJT

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNFFJT

text: not provided


COG-UK/DHSC-CYNOCPM

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYNOCPM

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNOCPM

text: not provided


COG-UK/DHSC-CYBHEPA

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBHEPA

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBHEPA

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYYOKQP

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYOKQP

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYOKQP

text: not provided


COG-UK/DHSC-CYBJEBZ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBJEBZ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBJEBZ

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDFKPD

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDFKPD

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDFKPD

text: not provided


COG-UK/DHSC-CYDAICU

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDAICU

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDAICU

text: not provided


COG-UK/DHSC-CYDEYGI

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYDEYGI

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDEYGI

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBUXRI

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBUXRI

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBUXRI

text: not provided


COG-UK/DHSC-CYBMMXW

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBMMXW

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBMMXW

text: not provided


COG-UK/DHSC-CYDJFUU

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDJFUU

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDJFUU

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBDKPJ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYBDKPJ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBDKPJ

text: not provided


COG-UK/DHSC-CYBKRTA

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYBKRTA

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBKRTA

text: not provided


COG-UK/DHSC-CYYRESZ

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYYRESZ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYRESZ

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDHFZR

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDHFZR

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDHFZR

text: not provided


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided


COG-UK/DHSC-CYDNBCW

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYDNBCW

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDNBCW

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNHWEI

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC first public

text: public

text: COG-UK/DHSC-CYNHWEI

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNHWEI

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: INSDC center name

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

tag: Namespace:Swedish University of Agricultural Sciences

characteristic: Submitter Id

unit: L

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

text: Untreated wastewater was collected in Kalmar at Kalmarsundsverket on 2021-12-13 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

unit: DD

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Kalmar

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Kalmarsundsverket

characteristic: name of the sampling site

text: Ion AmpliSeq SARS-CoV-2 Insight Research Assay with SuperScript™ VILO™ cDNA Synthesis Kit using Ion Chef™ (Thermo Fisher, # A51306, # 11754050, # MAN0019277, Rev B.0, pp. 3-4, # MAN0024915 Rev B.0, Ch 4, pp. 42-43)

characteristic: nucleic acid amplification

text: TNA concentration using Maxwell RSC Enviro Total Nucleic Acid Kit (Promega, # AS1831 & # TM663 Rev 4/22)

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

unit: day

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

text: 24 hour period, using a flow compensated sampler

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W50 Kalmar Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Swedish University of Agricultural Sciences

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Kalmar at Kalmarsundsverket on 2021-12-20 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Kalmar

text: virus

text: Kalmarsundsverket

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2021-W51 Kalmar Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: public

text: not provided

text: Untreated wastewater was collected in Kalmar at Kalmarsundsverket on 2021-12-27 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Kalmar

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Kalmarsundsverket

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W52 Kalmar Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Kalmar at Kalmarsundsverket on 2022-01-03 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Kalmar

text: virus

text: Kalmarsundsverket

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2022-W1 Kalmar Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: public

text: not provided

text: Untreated wastewater was collected in Kalmar at Kalmarsundsverket on 2022-01-10 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Kalmar

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Kalmarsundsverket

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2022-W2 Kalmar Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Umeå at Öns reningsverk on 2021-12-13 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Umeå

text: virus

text: Öns reningsverk

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2021-W50 Umeå Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: public

text: not provided

text: Untreated wastewater was collected in Umeå at Öns reningsverk on 2021-12-20 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Umeå

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Öns reningsverk

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

text: Severe acute respiratory syndrome coronavirus 2

characteristic: surveillance target (scientific name)

text: 2021-W51 Umeå Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Umeå at Öns reningsverk on 2021-12-27 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Umeå

text: virus

text: Öns reningsverk

text: Ion AmpliSeq SARS-CoV-2 Insight Research Assay with SuperScript™ VILO™ cDNA Synthesis Kit using Ion Chef™ (Thermo Fisher, # A51306, # 11754050, # MAN0019277, Rev B.0, pp. 3-4, # MAN0024915 Rev B.0, Ch 4, pp. 42-43)

text: TNA concentration using Maxwell RSC Enviro Total Nucleic Acid Kit (Promega, # AS1831 & # TM663 Rev 4/22)

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2021-W52 Umeå Amplified SARS-CoV-2 RNA from wastewater

characteristic: title